Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors

Molecular Medicine

Volumn 3, Issue 12, 1997, Pages 813-825

  Fraefel, Cornel ^a,c   Jacoby, David R ^a   Lage, Christopher ^a   Hilderbrand, Harold ^a   Chou, Janice Y ^b   Alt, Fred W ^a   Breakefield, Xandra O ^a   Majzoub, Joseph A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL STRAIN BHK; FIBROBLAST; GENE EXPRESSION REGULATION; GENE TRANSFER; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; LIVER CELL; MICROPHOTOGRAPHY; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0031424071     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401718     Document Type: Article

References (45)

1. Strauss M. (1994) Liver-directed gene therapy: prospects and problems. Gene Ther. 1: 156-164.
2. Mulligan RC. (1993) The basic science of gene therapy. Science 260: 926-932.
3. Ferry N, Duplessis O, Houssin D, Danos O, Heard JM. (1991) Retroviral-mediated gene transfer into hepatocytes in vivo. Proc. Natl. Acad. Sci. U.S.A. 88: 8377-8381.
4. Rettinger SD, Kennedy SC, Wu X, et al. (1994) Liver-directed gene therapy: Quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc. Natl. Acad. Sci. U.S.A. 91: 1460-1464.
5. Jaffe H, Danel C, Longenecker G, et al. (1992) Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat. Genet. 1: 372-378.
6. Kay MA, Landen CN, Rothenberg SA, et al. (1994) In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc. Natl. Acad. Sci. U.S.A. 91: 2353-2357.
7. Ohashi T, Watabe K, Uehara K, Sly WS, Vogler C, Eto Y. (1997) Adenovirus-mediated gene transfer and expression of human beta-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice. Proc. Natl. Acad. Sci. U.S.A. 94: 1287-1292.
8. Yang Y, Wilson JM (1995) Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J. Immunol. 155: 2564-2570.
9. Jooss K, Yang Y, Wilson JM. (1996) Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Hum. Gene Ther. 7: 1555-1566.
10. Gao GP, Yang Y, Wilson JM. (1996) Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 70: 8934-8943.
11. Berns KI. (1996) Parvoviridae: The viruses and their replication. In: Fields BN, Knipe DM, Howley PM (eds). Virology, 3rd ed. Lippincott-Raven, Philadelphia, pp. 2173-2197.
12. Flotte TR, Afione SA, Zeitlin PL. (1994) Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respir. Cell Mol. Biol. 11: 517-521.
13. Russel DW, Miller AD, Alexander IE. (1994) Adeno-associatcd virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. U.S.A. 91: 8915-8919.
14. McLaughlin SK, Collis P, Hermonat PL, Muzycka N. (1988) Adeno-associated virus general transduction vectors: Analysis of proviral structures. J. Virol. 62: 1963-1973.
15. Walsh CE, Liu JM, Xiao X, Young NS, Nienhuis AW, Samulski RJ. (1992) Regulated high level expression of a human gammaglobin gene introduced into erythroid cells by an adeno-associated virus vector. Proc. Natl. Acad. Sci. U.S.A. 89: 7257-7261.
16. Linden RM, Winocour E, Berns KI. (1996) The recombination signals for adeno-associated virus site-specific integration. Proc. Natl. Acad. Sci. U.S.A. 93: 7966-7972.
17. Fisher KJ, Gao GP, Weitzman MD, DeMatteo R, Burda JF, Wilson JM. (1996) Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70: 520-532.
18. Koeberl DD, Alexander IE, Halbert CL, Russell DW, Miller AD. (1997) Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc. Natl. Acad. Sci. U.S.A. 94: 1426-1431.
19. Weitzman MD, Kyöstiö SRM, Kotin RM, Owens RA. (1994) Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci. U.S.A. 91: 5808-5812.
20. Balague C, Kalla M, Zhang WW. (1997) Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J. Virol. 71: 3299-3306.
21. Glorioso JC, Bender MA, Goins WF, DeLuca N, Fink DJ. (1995) Herpes simplex virus as a gene-delivery vector for the central nervous system. In: Kaplitt MG, Loewy AD (eds). Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press, New York, pp. 1-23.
22. Breakefield XO, Kramm CM, Chiocca EA, Pechan PA. (1995) Herpes simplex virus vectors for tumor therapy. In: Sobol RE, ScanIon KJ (eds). The Internet Book of Gene Therapy: Cancer Gene Therapeutics. Appleton and Lange, Stamford, CT, pp. 41-56.
23. Fraefel C, Breakefield XO, Jacoby D. (1998) HSV-1 amplicon. In: Chiocca EA, Breakefield XO (eds). Gene Therapy for Neurological Disorders and Brain Tumors. Humana Press, Totowa, NJ, pp. 63-82.
24. Miyanohara A, Johnson PA, Elam RL, et al. (1992) Direct gene transfer to the liver with herpes simplex virus type 1 vectors: Transient production of physiologically relevant levels of circulating factor IX. New Biol. 4: 238-246.
25. Lu B, Gupta S, Federoff HJ. (1995) Ex vivo hepatic gene transfer in mouse using a defective herpes simplex virus-1 vector. Hepatology 21: 752-759.
26. Fong Y, Federoff HJ, Brownlee M, Blumberg D, Blumgart LH, Brennan MF. (1995) Rapid and efficient gene transfer in human hepatocytes by herpes viral vectors. Hepatology 22: 723-729.
27. Johnson PA, Yoshida K, Gage FH, Friedman T. (1992) Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector. Mol. Brain Res. 12: 95-102.
28. Spaete RR, Frenkel N. (1982) The herpes simplex virus amplicon: Analyses of cis-acting replication functions. Cell 30: 295-304.
29. Fraefel C, Song S, Lim F, et al. (1996) Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol. 70: 7190-7197.
30. Aboody-Guterman KS, Pechan PA, Rainov NG, et al. (1997) Green fluorescent protein as a reporter for retrovirus and helper virus-free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivo. NeuroReport (in press).
31. Johnston KM, Jacoby D, Pechan P, et al. (1997) HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum. Gene Ther. 8: 359-370.
32. Lei K-J, Chen H, Pan C-J, et al. (1996) Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse. Nat. Genet. 13: 203-209.
33. Shelly LL, Lei K-J, Pan C-J, et al. (1993) Isolation of the gene for murine glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1A. J. Biol. Chem. 268: 21482-21485.
34. Pinkert CA, Ornitz DM, Brinster RL, Palmiter RD. (1987) An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Genes Dev. 1: 268-276.
35. Cunningham C, Davison AJ. (1993) A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 197: 116-124.
36. Alt FW, Rathbun G, Oltz E, Taccioli G, Shinhai Y. (1992) Function and control of recombination-activating gene activity. Ann. NY Acad. Sci. 657: 277-294.
37. Lei K-J, Shelly LL, Pan C-J, Sidbury JB, Chou JY. (1993) Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a. Science 262: 580-583.
38. Folkman J, Philippart A, Tze W-J, Crigler J. (1972) Portacaval shunt for glycogen storage disease: Value of prolonged intravenous hyperalimentation before surgery. Surgery 72: 306-314.
39. Geller AI, Breakefield XO. (1988) A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons. Science 241: 1667-1669.
40. Guo ZS, Wang LH, Eisensmith RC, Woo SLC. (1996) Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Ther. 3: 802-810.
41. Lu B, Federoff HJ. (1995) Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression. Hum. Gene Ther. 6: 419-428.
42. Babiss LE, Herbst RS, Bennet AL, Darnell JE. (1987) Factors that interact with the rat albumin promoter are present both in hepatocytes and other cell types. Genes Dev. 1: 256-267.
43. Carlson JA, Rogers BB, Sifers RN, Hawkins HK, Finegold MJ, Woo SLC. (1988) Multiple tissues express alpha 1-antitrypsin in transgenic mice and man. J. Clin. Invest. 82: 26-36.
44. Shen R-F, Clift SM, DeMayo JL, Sifers RN, Finegold MJ, Woo SLC. (1989) Tissue-specific regulation of human alpha 1-antitrypsin gene expression in transgenic mice. DNA 8: 101-108.
45. Ward P, Berns KI. (1996) In vitro replication of adeno-associated virus DNA: Enhancement by extracts from adenovirus-infected HeLa cells. J. Virol. 70: 4495-4501.